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Abstract: The aim of the current study was to evaluate the
effect of a calcium phosphate material equipped with poly
(lactic-co-glycolic acid) microspheres for pulp capping, and
to measure the dentin bridge formation, when using various
concentrations of transforming growth factor (TGF) b1. Pre-
set samples were made (2 mm diameter; 2 mm height), con-
taining 0 (controls), 20, or 400 ng TGF-b1. These were placed
in goat incisors. Incisors capped with glass-ionomer cement
only were used as negative controls. Twelve weeks after
pulp capping, the incisors were retrieved, processed for his-
tology, and graded on basis of tertiary dentin formation. The
results showed that new dentin formation was seen in all
samples, except the negative controls. The histological grad-
ing indicated signiﬁcant differences between the samples
loaded with high amount of TGF-b1 versus the three other
groups (p < 0.05). In conclusion, our study demonstrated
that the composite with 400 ng TGF-b1 was able to trigger
resident stem cells in the pulp to differentiate into odonto-
blast-like cells and to induce the formation of tertiary dentin.
The material might be a good candidate for vital pulp
therapy. Production and manipulation methods could be
improved for follow-up studies.  2007 Wiley Periodicals,
Inc. J Biomed Mater Res 85A: 439–444, 2008
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INTRODUCTION
Although application of calcium hydroxide is a
treatment option to encourage hard tissue bridging
after dental pulp capping, the material is not able to
really induce new tissue formation.1 It has been sug-
gested that tissue engineering techniques can offer a
solution for this problem.2 One approach is the de-
velopment of a conductive scaffold that releases
morphogenetic signals as required to induce the resi-
dent stem cells as present in the dental pulp to
regenerate the new tooth tissue.
Transforming growth factor bs (TGF-bs) are a
group of proteins that play a role in embryonal de-
velopment, cellular differentiation, hormone secre-
tion, and immune function. TGF-b has three highly
similar isoforms, namely, TGF-b1, TGF-b2, and TGF-
b3. In human teeth, odontoblasts express all three
isoforms of TGF-b. However, only TGF-b1 becomes
sequestered within the matrix.3
During tooth formation, TGF-b1 is at ﬁrst highly
expressed in the epithelium. Subsequently, this high
expression shifts to the related mesenchyme.4 This sug-
gests that TGF-b1 plays an important role during tooth
formation. It has been proven that TGF-b1 can directly
induce the differentiation of odontoblast-like cells, and
upregulate the secretion of matrix components in the
dentin-pulp complex.5 The dentinogenic activity of
EDTA-dissolved dentin is hampered when the mate-
rial is preincubated with an anti-TGF-b1 antibody.6
When TGF-b1 is applied on tooth slices, which are cul-
tured in vitro, increased cell proliferation was observed
in the subodontoblastic layer, and in the underlying
pulp.7 Consequently, it seems that TGF-b1 might be a
good candidate to apply when regenerating the den-
tin-pulp complex, for instance after pulp capping.
An alternative for calcium hydroxide as pulp-
capping material is self-setting calcium phosphate
cement. Self-setting calcium phosphate materials
have been widely used for orthopaedic treatment,
because they are highly biocompatible, and have the
potential to stimulate osteogenesis. Their injectability
and setting/cohesion properties add more value to
such materials. It has been proven that self-setting
calcium phosphate cements show similar biocompat-
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ibility to pure calcium hydroxide. Also the effect in
dentin bridging, when used as a direct pulp capping
agent, is comparable between both materials.8
On basis of the above-mentioned, it can be hypothe-
sized that the biological properties of the cement can be
further optimized by bringing hydrosoluble polymers
(like polylactic-glycoloc acid) into the calcium phos-
phate, which subsequently can act as vehicles for the
delivery of signal molecules that stimulate the differen-
tiation of naturally present stem cells into odontoblasts,
and thus results in a biological means of regeneration
through enhanced tertiary dentin formation. The
degradable microparticles can offer a long-term release
of the bioactive molecules, but the particles will also
account for porosities, after polymer degradation, which
can provide the necessary space for tissue ingrowth.
Therefore, the aim of the current study was to
evaluate the effect of a calcium phosphate/hydrosol-
uble polymer composite for pulp capping, and to
measure the dentin bridge formation, when using
various concentrations of TGF-b1.
MATERIALS AND METHODS
Preparation of capping agents
Poly(lactic-co-glycolic acid) PLGA microspheres were pre-
pared by a double-emulsion-solvent-evaporation technique
(w/o/w).9 In brief, 1.0 g of PLGA was dissolved in 4 mL of
dichloromethane (DCM). Then, 500 lL of MilliQ and 6 mL
of a 0.3% poly(vinyl alcohol) (PVA) solution were added
while vigorously vortexing. Subsequently, 394 mL of 0.3%
PVA and 400 mL of a 2% isopropylic alcohol (IPA) solution
were slowly added. The formed particles were allowed to
settle and the supernatant was discarded. Finally, the par-
ticles were lyophilized, and stored in Argon at 208C.
Shortly before use, PLGA microparticles were sub-
merged in (0.1% Bovine serum albumin/phosphate-buf-
fered saline solution; BSA/PBS) solutions with different
concentrations of TGF-b1, lyophilized overnight and stored
at 208C until the next day. The density of TGF-b1 was
calculated according to the amount of PLGA particles, in
order to reach ﬁnal concentrations of 20 or 400 ng per cap-
ping material. Also, CaP cement/ PLGA composite sam-
ples with no added growth factor were made.
The CaP cement used was composed of 62.5% a-trical-
cium phosphate (a-TCP), 26.8% dicalcium phosphate
(DCPA), 3.9% CaCO3, and 1.8% hydroxyapatite (HAP),
and sterilized by g-irradiation. A 80/20 (w/w) CaP
cement/PLGA composite was prepared, that is, 2 mg
PLGA/ TGF-b1 microparticles was added to 8 mg of CaP
cement. The PLGA/CaP powder was mixed with 4 lL of
1% Na2HPO4 to create a paste. After vigorously stirring,
the prepared mixture was injected into cylindrical moulds
of 2 mm in diameter and 2 mm in depth under aseptic
conditions. All preset implants were dried overnight and
then stored at 208C until use in the animal study. Finally,
several samples of each group were ﬁxed and analyzed by
scanning electron microscopy (SEM).
Animal model and pulp capping procedure
Incisors of healthy mature female Saanen goats (age ¼ 3 6
1 years) were chosen as experimental model. Approval for
the study was obtained from the Radboud University Nijme-
gen Animal Ethical Committee (RU-DEC-2005-030). Further,
only goats already involved in other experiments were used.
The placement of the pulp capping cement was performed
under general anaesthesia, induced by an intravenous injec-
tion of Pentobarbital and maintained by Isoﬂurane 2%–4%.
In order to reduce the possibility of infection, antibiotics
(Albipen1) were given during the operation (3 mL/50 kg
s.c), one day after the operation (7.5 mL/50 kg s.c), and
3 days after the operation (7.5 mL/50 kg s.c). All goats
received analgesic (Finadyne1) for 2 days postoperatively.
Before pulp capping, the oral cavity, and especially the
tooth surface, was cleaned with povidone-iodine. Then,
cavities of 2.1 mm in diameter and 2.5 mm in depth were
prepared through the lingual surface of the tooth with a
sterile ball-shaped bur mounted on a conventional dental
hand-piece. During cavity preparation, sterile 0.9% saline
was used for cooling and removal of debris. After punctu-
ation of the dental pulp, haemostasis was controlled by a
sterile cotton pellet. The incisors were divided into four
different groups, and samples were available in sixfold (n
¼ 6) according to Table I. After installation of the various
composite materials, all cavities were closed with glass-
ionomer cement. Incisors capped with glass-ionomer
cement only were used as negative control.
Histological analysis
Twelve weeks after pulp capping, the goats were sacri-
ﬁced. The mandibles including incisors were surgically
dissected en bloc, divided through the mid-line, and ﬁxed
in 10% buffered formalin solution for 1 week. Subse-
quently, the biopsies were demineralized in Formical-2000
(Decal Chemical; Congers, NY) for 3 weeks at 48C with
continuous stirring. After dehydration, the demineralized
samples were embedded in parafﬁn. Buccal-labial serial
sections of 7 lm were cut. The sections through the expo-
sure sites were selected, stained with hematoxylin-eosin,
and evaluated using a light microscope.
Five sections from the centre of each sample were
assessed. Digitized photomicrographs were made, and the
samples were graded in a blinded manner by three inde-
pendent observers, according to the criteria described in
TABLE I
Study Groups in the Experiment
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Table II. All data were analyzed by an analysis of variance
(ANOVA) and post hoc Tukey testing.
RESULTS
Cement preparation
After mixing with Na2HPO4, the PLGA/CaP
cement was easy to inject into the molds. After hard-
ening, several samples from each group were
inspected with SEM microscopy, which indicated
that the PLGA microparticles were spherically
shaped with a diameter ranging from 20 to 50 lm.
The surface of the microparticles appeared smooth,
while only occasionally small pores were found on
the surface of particles. The distribution of PLGA
microparticles within cement was uniform. The addi-
tion of growth factors had no obvious inﬂuence as
the morphology or distribution of microparticles for
all three PLGA/CaP cements showed a similar
appearance upon qualitative inspection (Fig. 1).
Animal study
All goats appeared to be in good health through-
out the experimental period. No weight loss was
observed. No fracture or other damage was found in
any of the tested incisors. All incisors were retrieved
complete with surrounding tissues.
Light microscopy showed no mass inﬁltration of
inﬂammatory cells in any of the samples. Only occa-
sionally, inﬂammatory cells were detected in the
pulp near the treated sites. No distinct tissue degra-
dation was observed in any of the samples. Notice-
TABLE II
Histological Grading Scale
Dentin Bridge Formation Score
No visible hard tissue formation beneath or
around the exposed area
0
Initial signs of hard tissue formation beneath
or around the exposed area
1
Incomplete bridge-like hard tissue formation
beneath or around the exposed area
2
Complete bridge formation beneath or around
the exposed area
3
Figure 1. Scanning electron micrographs of samples before use; (A) 3100 overview of PLGA/CaP cement (B) higher
magniﬁcation of the microparticles at 3500 (C) cement and microparticles loaded with the high low of TGF-b1, 3500 (D)
cement and microparticles loaded with the high dose of TGF-b1, 3500.
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ably, in the sections of the negative control samples
(receiving glass ionomer cement only) the soft tissue
of the pulp was no longer in contact with the sur-
rounding dentin, but had detached over the largest
part. This detached area extended to more than half
of the length of the pulp. Furthermore, for the teeth
provided with the various CaP/PLGA cements, it
was observed that the PLGA microparticles had not
fully degraded after 12 weeks. Nondegraded poly-
mer particles were found in most of the remaining
capping materials (Fig. 2).
In all sections, it seemed that tissue had lost its
original integrity during the histological preparation.
Although all tissues were present in the samples, of-
ten between tissue layers empty voids were
observed. Still, new dentin formation was clearly
present in the samples (Fig. 3). Occasionally, a den-
tin-like tubular structure was observed in the newly
formed reparative dentin. Complete dentin-bridge
was found only in one of the samples capped by
PLGA/CaP cement with the high amount of TGF-
b1. No hard tissue formation at all was found in any
of the negative control incisors capped directly with
glass-ionomer cement. The histological grading scores
for all four groups are presented in Table III.
Statistical analysis indicated signiﬁcant differences
between the samples loaded with high amount of
TGF-b1 versus the three other groups (p < 0.05). No
difference (p > 0.05) existed between the samples
loaded with low amount of TGF-b1 and the samples
loaded with PLGA/CaP cement without added
growth factor. However, when the data of the low
concentration and nonloaded cement group were
pooled, they showed a signiﬁcant difference (p <
0.05) compared to the negative control group using
glass ionomer cement only.
DISCUSSION
The objective of this study was to evaluate the
effect of a calcium phosphate/ hydrosoluble polymer
composite for pulp capping, and to measure the
dentin bridge formation, when using various concen-
trations of TGF-b1. Results showed two evident
effects. First, the used PLGA/CaP composite
enhanced tertiary dentin formation, and second, this
process was enhanced considerably by the addition
of 400 ng of TGF-b1.
The importance of maintaining the vitality of the
dental pulp is widely accepted. The possibility of
exposed pulps to heal and form reparative dentin
has been conﬁrmed by numerous researchers.10,11
However, vital pulp capping is known to have a
very variable prognosis.12,13 Numerous factors may
inﬂuence the healing process of the dental pulp,
including the condition of the pulp itself, the restora-
tive manipulation, the applied capping material, and
so forth. Amongst these, the selection of an appro-
priate capping material is one of the essential factors.
The most commonly used materials for dental pulp
capping are various forms of calcium hydroxide,
and the odontogenetic effect of such materials has
Figure 2. Remnants of the PLGA/CaP cement in a control
sample. Arrow indicates nondegraded polymer particles
(bar: 10 lm). [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
Figure 3. The formation of tertiary dentin in a sample
with the high concentration TGF-b1. P, pulp tissue; D,
existing dentin; N, new formed dentin; V, void due to his-
tological preparation (bar: 25 lm). [Color ﬁgure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
TABLE III
Average Scores of the Histological Grading
of Six Samples by the 3 Observers
Group Score (6SD)
TGF-b1 (high dose) 1.72 (60.85)
TGF-b1 (low dose) 0.89 (60.50)
PLGA/CaP control 0.78 (60.50)
Negative control 0.06 (60.14)
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been conﬁrmed in many studies. One previous study
proved that self-setting calcium phosphate cements
show similar biocompatibility to pure calcium hy-
droxide. Also the effects, when used as a direct
pulp-capping agent, are comparable between both
materials.8 This was the rationale for using CaP ma-
terial in the current study.
It should be noticed that the degradation ability of
a solid calcium phosphate cement is fairly low, espe-
cially when applied in tooth cavity, which is a com-
paratively entrapped environment with limited
blood supply. Low degradation rates thus could
have a hampering effect on new tissue ingrowth and
replacement. In our study, we therefore opted for a
cement previously validated in bone regeneration
studies, which was equipped with degradable PLGA
particles into the calcium phosphate matrix.
Noticeably, the nonloaded cement/polymer com-
posite was beneﬁcial when compared to using glass
ionomer cement only. Further bioactive properties
were introduced in the cement by the addition of a
growth factor. The odontogenic properties of TGF-b1
have been proven in previous studies, which indi-
cated that TGF-b1 indeed is an appropriate candi-
date to apply when regenerating the dentin-pulp
complex, for instance after pulp capping. However,
the appropriate concentration for TGF-b1 (or any
other growth factor) to support pulp stem cell differ-
entiation remains difﬁcult to determine. There is no
previous literature on the application of TGF in this
model. According to two previous reports,14,15 two
distinct concentrations of 20 or 400 ng of TGF-b1
were chosen for the current study, although the
Tziafas study used a different release system/animal
model, and the Goldberg study used another growth
factor. Still, the formation of tertiary dentin in our
study supported the possibility to use PLGA/CaP
cement loaded with TGF-b1 for dental capping in a
dose-dependent way. The amount of new regener-
ated dentin in the samples loaded with the higher
dose of TGF-b1 was superior to the other study
groups. However, the samples capped with lower
dose of TGF-b1 (20 ng/tooth) were not effective and
illustrated similar dentin formation as the samples
capped with PLGA/CaP cement without TGF-b1. In
this, it could very well be that the degradation of the
polymer was insufﬁcient to release the 20 ng dose of
the growth factor.
An intriguing observation was the presence of
microparticles at the end of the study. Previous im-
plantation experiments in bone and soft tissue
showed that the polymer microparticles degrade rel-
atively fast, which allowed tissue ingrowth in the
emptied porosity.16,17 In our study however, even af-
ter 12 weeks microparticles were often seen to have
remained undegraded. The small volume and lim-
ited blood supply of the dental pulp might be the
reason for this phenomenon. This would implicate
that the cement we used, with optimal properties for
bone ingrowth, should be further adapted to the spe-
ciﬁc application into the pulp.
A ﬁnal noticeable histological observation was the
existence of empty spaces in most of the samples,
where tissue layers were no longer connected. These
might have been caused by a (too) high deminerali-
zation speed of the Formical, which caused artifacts
disrupting the integrity of the specimens. Some open
spaces in the tissue might also have partially been
caused by the use of our pre-fabricated material.
Since the drilling hole will always be slightly larger
than the sample itself it is almost impossible to
avoid a gap between the capping material and the
tooth. For clinical application, an injectable cement
would be optimal. However, with a size of only 2
mm in diameter and 2–3 mm in height it is hard to
maintain the stability of prepared materials, and
especially difﬁcult to control the accurate concentra-
tion of growth factor. Therefore, we chose the pre-
fabricated method to prepare the capping PLGA/
CaP cement with same dose of TGF-b1 in the entire
batch, in order to achieve more reliable and compa-
rable results. Future studies should elaborate on the
injectable concept to greater extent.
In conclusion, our study demonstrated that the
prefabricated PLGA/CaP cement loaded with 400 ng
of TGF-b1 was able to trigger resident stem cells in
the pulp to differentiate into odontoblast-like cells
and to induce the formation of tertiary dentin. The
material might be a good candidate for vital pulp
therapy. Production and manipulation methods
could be improved for follow-up studies.
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